Episurf Medical changes date for Annual General Meeting and financial reporting
Episurf Medical (Nasdaq: EPIS B) has today decided to change the date of the Annual General Meeting 2026 as well as the publication dates for the interim report for January-March 2026 and the Annual Report for 2025.
The publication of the Annual Report for 2025 is rescheduled from 6 March 2026 to 20 March 2026.
The Annual General Meeting 2026 is rescheduled from 10 April 2026 to 25 May 2026.
The interim report for the period January-March 2026 is rescheduled from 24 April 2026 to 25 May 2026.
An updated financial calendar will be available on the company's website.
For further information, please contact:
Sanja Batljan, CFO, Episurf Medical
Email: sanja.batljan@episurf.com
The information was submitted for publication, through the agency of the contact person set out above, at 08.30 CEST on 5 March 2026.
About Episurf
Episurf Medical is a newly created real estate company with exposure to a diversified portfolio of real estate assets. The Company aims to deliver expansive value creation through Nordic high-yielding properties. The Company also has a medical technology business which is based on the individualised implant Episealer® and related surgical instruments, which are used for treating cartilage damage in joints. Episurf Medical's head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, visit the company's website: www.episurf.com.